Incyte Reports 2024 Second Quarter Financial Results and Provides Updates on Key Clinical Programs

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. NKE
8. MU
9. ACN
10. USO

Go back to Incyte Reports 2024 Second Quarter Financial Results and Provides Updates on Key Clinical Programs

Incyte (INCY) PT Raised to $66 at RBC Capital

July 31, 2024 6:22 AM EDT

RBC Capital analyst Brian Abrahams raised the price target on Incyte (NASDAQ: INCY) to $66.00 (from $61.00) while maintaining a Sector Perform rating.

The analyst comments "Solid, albeit mostly expected, operational quarter with fewer inventory, g/n, and seasonality headwinds for Jakafi and... More